1095274-55-7

Usage

Uses

Used in Organic Synthesis:
Ethyl 3-bromo-5-chlorobenzoate is used as a building block in organic synthesis for the creation of more complex compounds. Its unique structure allows it to be a key component in the synthesis of various organic molecules.
Used in Pharmaceutical Manufacturing:
In the pharmaceutical industry, ethyl 3-bromo-5-chlorobenzoate is used as an intermediate in the production of various drugs. Its reactivity and functional groups make it suitable for the synthesis of pharmaceutical compounds with specific therapeutic properties.
Used in Agrochemical Development:
Ethyl 3-bromo-5-chlorobenzoate is also utilized in the development of agrochemicals, such as pesticides and herbicides. Its chemical properties enable it to be incorporated into the design of effective and targeted agrochemicals.
Used in Heterocycle Formation:
ethyl 3-bromo-5-chlorobenzoate is used as a reagent in the formation of heterocycles, which are important structural motifs in many biologically active molecules and pharmaceuticals. Its ability to participate in cyclization reactions contributes to the synthesis of diverse heterocycles.
Used in Research and Development:
Ethyl 3-bromo-5-chlorobenzoate is employed in research and development settings to explore its potential applications and reactions. Its versatility in organic chemistry makes it a valuable tool for scientists to study and develop new compounds and reactions.

Upstream product

• 64-17-5 ethanol 
• 42860-02-6 3‐bromo‐5‐chlorobenzoic acid 

Downstream Products

• 1095274-81-9 ethyl 3-chloro-5-[(1E)-3-(ethyloxy)-3-oxo-1-propen-1-yl]benzoate 
• 1095274-69-3 1,1-dimethylethyl 4-{3-chloro-5-[(ethyloxy)carbonyl]phenyl}-3,6-dihydro-1(2H)-pyridinecarboxylate 
• 1095274-56-8 3-bromo-5-chlorobenzohydrazide 
• 1095274-82-0 ethyl 3-chloro-5-[3-(ethyloxy)-1-(nitromethyl)-3-oxopropyl]benzoate 
• 1095274-58-0 {5-[3-chloro-5-(1-{[(1,1-dimethylethyl)oxy]carbonyl}-1,2,3,6-tetrahydro-4-pyridinyl)phenyl]-1,3,4-oxadiazol-2-yl}acetic acid lithium salt 
• 1095274-16-0 1,1-dimethylethyl 4-[3-chloro-5-(5-{2-oxo-2-[4-(2-oxo-1,2,4,5-tetrahydro-3H-1,3-benzodiazepin-3-yl)-1-piperidinyl]ethyl}-1,3,4-oxadiazol-2-yl)phenyl]-1-piperidinecarboxylate 
• 1095273-72-5 1,1-dimethylethyl 4-[3-chloro-5-(5-{2-oxo-2-[4-(2-oxo-1,2,4,5-tetrahydro-3H-1,3-benzodiazepin-3-yl)-1-piperidinyl]ethyl}-1,3,4-oxadiazol-2-yl)phenyl]-3,6-dihydro-1(2H)-pyridinecarboxylate 
• 1095274-10-4 3-[1-({5-[3-chloro-5-(1-methyl-1,2,3,6-tetrahydro-4-pyridinyl)phenyl]-1,3,4-oxadiazol-2-yl}acetyl)-4-piperidinyl]-1,3,4,5-tetrahydro-2H-1,3-benzodiazepin-2-one 
• 1095274-01-3 3-[1-({5-[3-chloro-5-(4-piperidinyl)phenyl]-1,3,4-oxadiazol-2-yl}acetyl)-4-piperidinyl]-1,3,4,5-tetrahydro-2H-1,3-benzodiazepin-2-one 
• 1095273-70-3 3-[1-({5-[3-chloro-5-(5-pyrimidinyl)phenyl]-1,3,4-oxadiazol-2-yl}acetyl)-4-piperidinyl]-1,3,4,5-tetrahydro-2H-1,3-benzodiazepin-2-one 
• 1095274-57-9 1,1-dimethylethyl 4-(3-chloro-5-{5-[2-(ethyloxy)-2-oxoethyl]-1,3,4-oxadiazol-2-yl}phenyl)-3,6-dihydro-1(2H)-pyridinecarboxylate 
• 1095274-70-6 1,1-dimethylethyl 4-{3-chloro-5-[(ethyloxy)carbonyl]phenyl}-1-piperidinecarboxylate 
• 1095274-74-0 ethyl 3-chloro-5-[1-(2,2,2-trifluoroethyl)-4-piperidinyl]benzoate 
• 1095274-73-9 ethyl 3-chloro-5-[1-(2,2,2-trifluoroethyl)-1,2,3,6-tetrahydro-4-pyridinyl]benzoate 

Relevant academic research and scientific papers

5-PHENYL-1,3,4-OXADIAZOL-2-YL-ACETYL-4-PIPERIDINYL DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS

The present invention relates to novel compounds that are CGRP receptor antagonists, processes for their preparation, to compositions containing them and to their use in the treatment of migraine, headache, and cluster headache.